Cuprina Holdings (Cayman) LTD

Cuprina Holdings (Cayman) LTD (CUPR) priced its initial public offering on Apr 10, 2025 at $4.00 per share, raising $12M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $84M. R.F. Lafferty was lead-left underwriter. Loeb & Loeb and Harneys advised the company and Winston & Strawn advised the underwriters.

Cuprina Holdings (Cayman) LTD is a Singapore-based biomedical company developing wound care products for chronic wounds, plus health and beauty products. Its MEDIFLY products are used as a biological debridement tool in maggot debridement therapy.

Status

IPO

Ticker

CUPR

Exchange

Nasdaq Capital Market

Priced

Apr 10, 2025

IPO price

$4.00

Raised

$12M

Market cap at IPO price

$84M

First filed

Mar 7, 2024

Underwriters

R.F. Lafferty

Company counsel

Loeb & Loeb and Harneys

Underwriters' counsel

Winston & Strawn

Sector

Healthcare

Country / state

Singapore

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.